THE VERITY LIBERATE

 ~Preet The writer or publisher has no rights to this image. This image is taken from  crisprcas9-genome-editing-technology-that-260nw-1121736050.jpg In 2021, India will launch a five-year initiative to produce Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) to treat sickle cell anaemia. In India, sickle cell anaemia is the first illness targeted for CRISPR-based treatment. The pre-clinical phase (animal studies) is set to commence. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene editing system that uses a specific enzyme called Cas9 to mimic bacteria's natural defence mechanism against viral assaults. It generally entails the insertion of a new gene or the silencing of an existing gene via a process known as genetic engineering. CRISPR technique does not entail the insertion of any new genes from outside sources. CRISPR-Cas9 technology is frequently referred to as 'Genetic Scissors.' Its method is sometimes equated to the 

 ~Preet The Minister of State for Electronics and Information Technology (IT) recently remarked on the need for a legal update of the 22-year-old Information Technology Act, 2000. The first IT Act was adopted by the government in 2000. The IT (Amendment) Act went into effect in 2009, with the goal of promoting e-governance, reducing cybercrime, and encouraging security practises throughout the country. The government has published the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules 2021. In a few years, India will have a trillion-dollar digital economy, and a big number of firms will be on the Indian Internet. As a result, an open and secure Internet becomes a critical economic component of our society. Because of aggressive national policies, trade conflicts, censorship, and frustration with giant tech corporations, the global internet as we know it is on the point of splintering into smaller bubbles of national networks. This will have far-reachin

 ~Preet. The European Space Agency's ExoMars 2022 mission will not launch as scheduled in September 2022, since the agency has halted all collaboration with Russia's space programme Roscosmos. Previously, Russia's space agency ROSCOSMOS stated that it will not work with Germany on cooperative experiments in the Russian component of the International Space Station (ISS). It is a two-stage project, with the first stage launched in 2016 atop a Proton-M rocket, consisting of the European Trace Gas Orbiter and a test lander dubbed Schiaparelli. The orbiter was successful, but the test lander failed on its way to Mars. The second stage of the mission, which includes a rover and a surface platform, was initially scheduled for July 2020. However, due to technological difficulties, it was postponed until September. The European Space Agency (ESA) and the National Aeronautics and Space Administration (NASA) were the original ExoMars collaborators, however NASA withdrew out in 2012 ow